Cargando…
EVALI Vaping Liquids Part 1: GC-MS Cannabinoids Profiles and Identification of Unnatural THC Isomers
Tetrahydrocannabinol (THC)-containing products played a major role in the 2019 US nationwide outbreak of pulmonary lung illness associated with e-cigarettes or vaping liquids (EVALI). Due to the severity of the illness which resulted in 68 deaths, a comprehensive identification of the components in...
Autores principales: | Ciolino, Laura A., Ranieri, Tracy L., Brueggemeyer, Jana L., Taylor, Allison M., Mohrhaus, Angela S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499677/ https://www.ncbi.nlm.nih.gov/pubmed/34631667 http://dx.doi.org/10.3389/fchem.2021.746479 |
Ejemplares similares
-
EVALI Vaping Liquids Part 2: Mass Spectrometric Identification of Diluents and Additives
por: Ciolino, Laura A., et al.
Publicado: (2021) -
A presentation of E-Cigarette vaping associated lung injury (EVALI) caused by THC-Containing electronic smoking device
por: Galo, Jason, et al.
Publicado: (2020) -
The EVALI outbreak and vaping in the COVID-19 era
por: The Lancet Respiratory Medicine
Publicado: (2020) -
Lipid-Laden alveolar macrophages and vaping: Lessons from EVALI
por: Jonas, Andrea
Publicado: (2020) -
E-CIGARETTE OR VAPING USE-ASSOCIATED LUNG INJURY (EVALI): EFFECTS OF VAPING OR COVID-19?
por: WALBRIDGE, GEORGE, et al.
Publicado: (2022)